Cost-effectiveness of a “treat-all” strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages

• Riichiro Suenaga,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Japanese Red Cross Yamaguchi Hospital, Yamaguchi, Yamaguchi, Japan

  https://orcid.org/0000-0002-4023-9628

  ⨯
• Machi Suka,

  Roles Data curation, Validation, Writing – review & editing

  Affiliation Department of Public Health and Environmental Medicine, The Jikei University of Medicine, Minato-ku, Tokyo, Japan

  ⨯
• Tomohiro Hirao,

  Roles Data curation, Funding acquisition, Validation, Writing – review & editing

  Affiliation Department of Public Health, Faculty of Medicine, Kagawa University, Kita-gun, Kagawa, Japan

  ⨯
• Isao Hidaka,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan

  ⨯
• Isao Sakaida,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan

  ⨯
• Haku Ishida

  Roles Conceptualization, Data curation, Formal analysis, Validation, Writing – original draft, Writing – review & editing

  * E-mail: hishida@yamaguchi-u.ac.jp

  Affiliation Department of Medical Informatics & Decision Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan

  https://orcid.org/0000-0002-7773-2555

  ⨯